BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34819933)

  • 1. Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The
    König E; Gagliardi A; Riedmiller I; Andretta C; Tomasi M; Irene C; Frattini L; Zanella I; Berti F; Grandi A; Caproni E; Fantappiè L; Grandi G
    Front Immunol; 2021; 12():752168. PubMed ID: 34819933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bacterial outer membrane vesicle-based click vaccine elicits potent immune response against
    Sun J; Lin X; He Y; Zhang B; Zhou N; Huang JD
    Front Immunol; 2023; 14():1088501. PubMed ID: 36742310
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine assembly from surface proteins of Staphylococcus aureus.
    Stranger-Jones YK; Bae T; Schneewind O
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16942-7. PubMed ID: 17075065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-minimized outer membrane vesicles from
    Zanella I; König E; Tomasi M; Gagliardi A; Frattini L; Fantappiè L; Irene C; Zerbini F; Caproni E; Isaac SJ; Grigolato M; Corbellari R; Valensin S; Ferlenghi I; Giusti F; Bini L; Ashhab Y; Grandi A; Grandi G
    J Extracell Vesicles; 2021 Feb; 10(4):e12066. PubMed ID: 33643549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad and Effective Protection against Staphylococcus aureus Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens.
    Deng J; Wang X; Zhang BZ; Gao P; Lin Q; Kao RY; Gustafsson K; Yuen KY; Huang JD
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus.
    Glowalla E; Tosetti B; Krönke M; Krut O
    Infect Immun; 2009 Jul; 77(7):2719-29. PubMed ID: 19364833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
    Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
    Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Haag AF; Liljeroos L; Donato P; Pozzi C; Brignoli T; Bottomley MJ; Bagnoli F; Delany I
    Microbiol Spectr; 2023 Feb; 11(1):e0257422. PubMed ID: 36688711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Begier E; Seiden DJ; Patton M; Zito E; Severs J; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
    Vaccine; 2017 Feb; 35(8):1132-1139. PubMed ID: 28143674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.
    Nieves W; Petersen H; Judy BM; Blumentritt CA; Russell-Lodrigue K; Roy CJ; Torres AG; Morici LA
    Clin Vaccine Immunol; 2014 May; 21(5):747-54. PubMed ID: 24671550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a Staphylococcus aureus-cholera toxin A
    Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
    Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice.
    Mishra RP; Mariotti P; Fiaschi L; Nosari S; Maccari S; Liberatori S; Fontana MR; Pezzicoli A; De Falco MG; Falugi F; Altindis E; Serruto D; Grandi G; Bagnoli F
    J Infect Dis; 2012 Oct; 206(7):1041-9. PubMed ID: 22829645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.